Peri-procedural ST segment resolution during Primary Percutaneous Coronary Intervention (PPCI) for acute myocardial

Grigoris V Karamasis1, Paul Russhard2, Firas Al Janabi1

  • 1Department of Cardiology, Essex Cardiothoracic Centre, Basildon, Essex, UK; Postgraduate Medical Institute, Anglia Ruskin University, Chelmsford, Essex, UK.

Insights

Intra-procedural ST segment resolution (STR) during periprocedural primary percutaneous coronary intervention (PPCI) in STEMI patients was achieved in less than half of cases. Good STR was linked to better outcomes, including shorter hospital stays and improved ejection fraction.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Acute Coronary Syndromes

Background:

  • ST segment resolution (STR) assesses myocardial perfusion in STEMI patients post-PPCI.
  • Previous studies often used ECGs recorded after the catheterization lab, limiting timely interventions.
  • Intra-procedural STR assessment is crucial for immediate therapeutic adjustments.

Purpose of the Study:

  • To investigate the occurrence of intra-procedural ST segment resolution (STR) during primary percutaneous coronary intervention (PPCI) for ST-elevation myocardial infarction (STEMI).
  • To evaluate the clinical consequences of achieving good STR within the catheterization laboratory.

Main Methods:

  • Analysis of 12-lead ECGs recorded at the onset and end of PPCI in 467 STEMI patients.
  • STR measured in the lead with maximal ST elevation, with "good" defined as >50% resolution.
  • Correlation of STR with patient demographics, infarct location, and procedural characteristics.

Main Results:

  • Good peri-procedural STR was observed in 46.5% of patients.
  • Good STR was more frequent in inferior infarcts, current smokers, and those with symptom onset < 4 hours.
  • Patients with good STR had higher rates of thrombus aspiration, shorter hospital stays, and improved LVEF.

Conclusions:

  • Less than half of STEMI patients achieved good peri-procedural STR during PPCI.
  • Good STR is associated with significant positive clinical outcomes.
  • Identifying suboptimal STR intra-procedurally may guide new microcirculation-protective therapies.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.1K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
309
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
315
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
477
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
1.6K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
315